This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Citizens Business Bank will acquire County Commerce Bank in a cash-and-stock deal, shrinking the number of community banks but vastly increasing the region’s lending capital. The proposed merger would strengthen Citizens’ commercial banking presence in Ventura County and fuel its regional expansion. Ontario-based Citizens, which has maintained a strong presence in the San Fernando Valley, Read More →
Community West Bancshares, parent company of Community West Bank headquartered in Goleta, reported on Oct. 22 net income of $1.6 million in the third quarter of 2015 compared to net income of $1.7 million in the third quarter a year ago. Community West reported net income of $1.0 million in the first nine months of Read More →
Shares of Sientra hit a new all-time low on Oct. 16 when the stock fell another six cents on the day and closed at $5.77 per share. For the Goleta-based breast implant manufacturer, it marks another low in a saga that’s starting to turn ugly. Shares of Sientra initially plummeted from $20.58 per share to Read More →
Appfolio is expanding in Goleta. Appfolio will lease an additional 7,855 square feet of space at its office at 50 Castilian Drive in Goleta, according to documents filed with the Securities and Exchange Commission on Oct. 14. The new space will increase the amount of space Appfolio leases from Nassau Land Company to 26,490 square Read More →
Kythera Biopharmaceuticals is permanently laying off 117 employees at its Westlake Village offices, according to a filing today with the Securities and Exchange Commission. The layoffs come as no surprise and appear to be part of Kythera’s merger with Dublin-based Allergan. On June 17, Allergan announced that it would buy Kythera for $2.1 billion. The Read More →
Thousand Oaks-based pharmaceutical giant Amgen announced results Oct. 12 showing its bone density drug Prolia reduced the incidences of bone fractures in post-menopausal women with osteoporosis over 10 years. Prolia is designed to raise bone density in people with a history of osteoporosis. Amgen released the data during the annual conference of the American Society Read More →
